Your browser doesn't support javascript.
loading
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation.
Harter, Patrick N; Weber, Katharina J; Ricklefs, Franz L; Drexler, Richard; Schüller, Ulrich; Hack, Marcel; Hanke, Tim; Dohmen, Hildegard; Acker, Till; von Deimling, Andreas; Hasselblatt, Martin; Divé, Iris; Unger, Kristian; Steinbach, Joachim P; Capper, David; Ronellenfitsch, Michael W.
Afiliación
  • Harter PN; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and University/University Hospital, LMU Munich, Munich, Germany.
  • Weber KJ; Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
  • Ricklefs FL; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.
  • Drexler R; Germany and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKFZ) Heidelberg, Frankfurt, Germany.
  • Schüller U; University Cancer Center (UCT), Goethe University Frankfurt, University Hospital, Frankfurt, Germany.
  • Hack M; Neurological Institute (Edinger Institute), Goethe University Frankfurt, University Hospital, Frankfurt, Germany.
  • Hanke T; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dohmen H; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Acker T; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • von Deimling A; Department of Pediatric Hematology and Oncology, Research Institute Children's Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hasselblatt M; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Divé I; Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
  • Unger K; Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
  • Steinbach JP; Institute of Neuropathology, Gießen University Hospital, Gießen, Germany.
  • Capper D; Institute of Neuropathology, Gießen University Hospital, Gießen, Germany.
  • Ronellenfitsch MW; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Neurooncol Adv ; 6(1): vdae138, 2024.
Article en En | MEDLINE | ID: mdl-39184173
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido